The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
LLMC 2020 | Transplantation for consolidation in multiple myeloma
Joseph Mikhael, MD, MEd, FRCPC, FACP, Translational Genomics Research Institute (TGen), City of Hope Cancer Center, CA, discusses the role of transplantation in consolidation of multiple myeloma (MM), outlining how transplant therapies contribute to the depth of response and highlighting recent studies showing a more durable response in MM patients who receive autologous stem cell transplants compared to those treated with non-transplant strategies. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
Disclosures
Consultant for Amgen, BMS, Karyopharm, Janseen, Sanofi and Takeda
